Form4insider filings, from the source

SEC Form 4 · accession 0001209191-19-016027

INTERMOLECULAR INC · IMI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Feb 28, 2019
Accepted (ET)
Mar 4, 2019 · 7:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001311241

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 28, 2019S171,045$1.00D7,252,346IBy Redpoint Ventures II, L.P.
Common StockF2Feb 28, 2019S3,955$1.00D167,693IBy Redpoint Associates II, LLC
Common StockF1Mar 1, 2019S24,435$1.00D7,227,911IBy Redpoint Ventures II, L.P.
Common StockF2Mar 1, 2019S565$1.00D167,128IBy Redpoint Associates II, LLC

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses